My watch list
my.bionity.com  
Login  

Olink Bioscience and Abnova signs co-marketing agreement to promote unique target-specific assays for cell signaling studies

20-Apr-2009

Olink Bioscience and Abnova Corporation announced a co-development and co-marketing agreement. This collaboration will address the unmet need for high-performance assays for studies of protein phosphorylation and protein interactions by combining Abnova´s growing collection of antibodies with the Duolink® product line from Olink Bioscience. Hundreds of target-specific assays will be jointly marketed by the two companies, while sales of the proprietary products will be handled by the respective companies and their distributors.

Facts, background information, dossiers
More about Abnova
  • News

    Abnova and Clearbridge BioMedics Accelerate Circulating Tumor Cell System into the Research and In Vitro Diagnostic Markets

    Abnova Corporation and Clearbridge BioMedics announced a collaboration to jointly develop a platform that provides a next generation, non-invasive “liquid biopsy” for cancer screening, staging, treatment, and monitoring. Through this collaboration, Abnova will leverage upon Clearbridge BioM ... more

  • Companies

    Abnova Corporation

    Abnova is the world's largest antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to h ... more

    Abnova GmbH

    Abnova is the world largest monoclonal antibody manufacturer. We have a capacity of generating 500 mouse monoclonal antibodies per month. Rather than the traditional method of monoclonal antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goa ... more

More about Olink Bioscience
  • News

    A new European Consortium to boost our understanding of Inflammatory Bowel Diseases

    The Inflammatory Bowel Disease characterization by a multi-modal integrated biomarker study (IBD-Character) Consortium is a collaborative effort to advance our understanding of the inflammatory bowel diseases Ulcerative Colitis and Crohn's Disease and to increase diagnostic precision in det ... more

    Phosphorylated Akt isoforms revealed as novel cancer biomarkers by Duolink

    The PI3K/Akt signal transduction pathway plays an important role in cancer progression and cell survival. A recent paper from John Bartlett’s research group now describes the use of in situ PLA as a tool to distinguish between the different activated isoforms of Akt in tissue from cancer pa ... more

    Olink Appoints New CEO and Expands Board of Directors

    Dr. Simon Fredriksson, Executive Vice President and Chief Scientific Officer of Olink AB (Olink) has been promoted to President and CEO of Olink. Simon Fredriksson is taking over from Björn Ekström who has been managing the company since its inception in 2004. At the same time new members o ... more

  • Companies

    Olink Bioscience

    Olink Bioscience is a privately held company based in Uppsala, Sweden, founded in 2004 by Prof. Ulf Landegren and partners. The company was initially founded on a portfolio of 12 patent cases, covering 4 technologies for advanced analyses of biomolecules pertaining to applications in basic ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE